Jodie Hay

8.2k total citations · 1 hit paper
20 papers, 606 citations indexed

About

Jodie Hay is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Jodie Hay has authored 20 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Genetics and 6 papers in Hematology. Recurrent topics in Jodie Hay's work include Chronic Lymphocytic Leukemia Research (5 papers), Acute Myeloid Leukemia Research (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Jodie Hay is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Acute Myeloid Leukemia Research (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Jodie Hay collaborates with scholars based in United Kingdom, Netherlands and Austria. Jodie Hay's co-authors include Ruth Studley, Emma Pritchard, Philippa C. Matthews, Ian Diamond, John I. Bell, John Newton, Karina-Doris Vihta, Jeremy Farrar, David W. Eyre and Thomas House and has published in prestigious journals such as Nature Medicine, Nature Communications and Scientific Reports.

In The Last Decade

Jodie Hay

20 papers receiving 592 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK

2021 330 citations Koen B. Pouwels, Emma Pritchard et al. Nature Medicine profile →

Peers

Countries citing papers authored by Jodie Hay

Since Specialization

Citations

This map shows the geographic impact of Jodie Hay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jodie Hay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jodie Hay more than expected).

Fields of papers citing papers by Jodie Hay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jodie Hay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jodie Hay. The network helps show where Jodie Hay may publish in the future.

Co-authorship network of co-authors of Jodie Hay

This figure shows the co-authorship network connecting the top 25 collaborators of Jodie Hay. A scholar is included among the top collaborators of Jodie Hay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jodie Hay. Jodie Hay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bioengineered niches that recreate physiological extracellular matrix organisation to support long-term haematopoietic stem cells 2024 ·Nature Communications ·Hannah Donnelly, Ewan A. Ross, Yinbo Xiao, (unknown), (unknown), (unknown), Jennifer Cassels, Penelope M. Tsimbouri, Karen Dunn, Jodie Hay, Annie Cheng, R.M.D. Meek, Nikhil Jain, Christopher C. West, Helen Wheadon, Alison M. Michie, Bruno Péault, Adam G. West, Manuel Salmerón‐Sánchez, Matthew J. Dalby	7
2	Implementation and adherence to regular asymptomatic testing in a COVID-19 vaccine trial 2024 ·Vaccine ·(unknown), Katherine R. W. Emary, Daniel J. Phillips, Jodie Hay, Jessica P. J. Larwood, Maheshi Ramasamy, Andrew J. Pollard, Nicholas C. Grassly, Merryn Voysey	1
3	mTORC1-selective activation of translation elongation promotes disease progression in chronic lymphocytic leukemia 2023 ·Leukemia ·(unknown), Jodie Hay, (unknown), Karen Dunn, (unknown), Jennifer Cassels, Jiatian Li, Rinako Nakagawa, Owen J. Sansom, Alison M. Michie	7
4	The discrete roles of individual FOXO transcription factor family members in B-cell malignancies 2023 ·Frontiers in Immunology ·(unknown), Jodie Hay, (unknown), Alison M. Michie	15
5	PKCβ Facilitates Leukemogenesis in Chronic Lymphocytic Leukaemia by Promoting Constitutive BCR-Mediated Signalling 2022 ·Cancers ·Jodie Hay, Anuradha Tarafdar, (unknown), (unknown), Karen Dunn, (unknown), Bryony H. Lloyd, Jennifer Cassels, (unknown), (unknown), (unknown), (unknown), (unknown), Nagesh Kalakonda, Joseph R. Slupsky, Alison M. Michie	3
6	SARS-CoV-2 Positivity in Asymptomatic-Screened Dental Patients 2021 ·Journal of Dental Research ·David I. Conway, Shauna Culshaw, (unknown), (unknown), Christopher Watling, Chris Robertson, (unknown), E. O’Keefe, (unknown), Joseph Burns, (unknown), Harper VanSteenhouse, Jodie Hay, Rory Gunson, (unknown)	21
7	Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK breakdown → 2021 ·Nature Medicine ·Koen B. Pouwels, Emma Pritchard, Philippa C. Matthews, Nicole Stoesser, David W. Eyre, Karina-Doris Vihta, Thomas House, Jodie Hay, John I. Bell, John Newton, Jeremy Farrar, Derrick W. Crook, Duncan Cook, Emma Rourke, Ruth Studley, Tim Peto, Ian Diamond, Andrew Walker	330
8	Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time 2021 ·eLife ·A. Sarah Walker, Emma Pritchard, Thomas House, Julie V. Robotham, Paul Birrell, Iain Bell, John I. Bell, John Newton, Jeremy Farrar, Ian Diamond, Ruth Studley, Jodie Hay, Karina-Doris Vihta, Timothy Peto, Nicole Stoesser, Philippa C. Matthews, David W. Eyre, Koen B. Pouwels, (unknown)	65
9	Collaboration of MYC and RUNX2 in lymphoma simulates T‐cell receptor signaling and attenuates p53 pathway activity 2019 ·Journal of Cellular Biochemistry ·Jodie Hay, Kathryn Gilroy, Camille Huser, Anna Kilbey, (unknown), Amanda MacCallum, (unknown), Ewan R. Cameron, James C. Neil	6
10	mTORC1 activity is essential for erythropoiesis and B cell lineage commitment 2019 ·Scientific Reports ·(unknown), Karen Dunn, Jennifer Cassels, Jodie Hay, (unknown), Owen J. Sansom, Alison M. Michie	7
11	Disrupting MLV integrase:BET protein interaction biases integration into quiescent chromatin and delays but does not eliminate tumor activation in a MYC/Runx2 mouse model 2019 ·PLoS Pathogens ·(unknown), Vasudevan Achuthan, Kathryn Gilroy, Gillian Borland, Anna Kilbey, Nancy MacKay, Margaret Bell, Jodie Hay, Sriram Aiyer, Dylan Fingerman, Rodrigo A. Villanueva, Ewan R. Cameron, Christine A. Kozak, Alan Engelman, James C. Neil, Monica J. Roth	8
12	Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking 2019 ·Journal of Visualized Experiments ·Jodie Hay, (unknown), Jennifer Cassels, Alison M. Michie	1
13	Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking 2019 ·Journal of Visualized Experiments ·Jodie Hay, (unknown), Jennifer Cassels, Alison M. Michie	1
14	AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival 2018 ·Clinical Cancer Research ·Emilio Cosimo, Anuradha Tarafdar, (unknown), (unknown), (unknown), Mark Catherwood, Jodie Hay, Karen Dunn, (unknown), Sylvie M. Guichard, Declan O’Rourke, (unknown), Owen J. Sansom, Sabina Cosulich, Alison M. McCaig, Alison M. Michie	23
15	The RUNX Genes as Conditional Oncogenes: Insights from Retroviral Targeting and Mouse Models 2017 ·Advances in experimental medicine and biology ·James C. Neil, Kathryn Gilroy, Gillian Borland, Jodie Hay, Anne Terry, Anna Kilbey	13
16	RUNX‐mediated growth arrest and senescence are attenuated by diverse mechanisms in cells expressing RUNX1 fusion oncoproteins 2017 ·Journal of Cellular Biochemistry ·Gail S. Anderson, Nancy MacKay, Kathryn Gilroy, Jodie Hay, Gillian Borland, (unknown), Margaret Bell, (unknown), Ewan R. Cameron, James C. Neil, Anna Kilbey	7
17	Integrated analysis of the molecular action of Vorinostat identifies epi-sensitised targets for combination therapy 2017 ·Oncotarget ·Jodie Hay, (unknown), Fabio G. Liberante, Laura M. Kettyle, Kyle B. Matchett, Alexander Thompson, Ken Mills	5
18	Addiction toRunx1is partially attenuated by loss of p53 in the Eμ-Myc lymphoma model 2016 ·Oncotarget ·Gillian Borland, Anna Kilbey, Jodie Hay, Kathryn Gilroy, Anne Terry, Nancy MacKay, Margaret Bell, (unknown), Ken Mills, Ewan R. Cameron, James C. Neil	6
19	Prognostic and therapeutic relevance of c‐FLIP in acute myeloid leukaemia 2012 ·British Journal of Haematology ·Donal P. McLornan, Jodie Hay, Kirsty M. McLaughlin, Caitriona Holohan, Alan K. Burnett, Robert K. Hills, Patrick G. Johnston, Ken Mills, Mary Frances McMullin, Daniel B. Longley	38
20	Colonization of transplant unit water supplies with Legionella and protozoa: precautions required to reduce the risk of legionellosis 1997 ·Journal of Hospital Infection ·W. J. Patterson, Jodie Hay, D.V. Seal, (unknown)	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact